Status:

COMPLETED

Clinical Evaluation of Primary Sampling Scatter Correction for Chest Tomosynthesis

Lead Sponsor:

UNC Lineberger Comprehensive Cancer Center

Collaborating Sponsors:

National Cancer Institute (NCI)

Conditions:

Pulmonary Nodule, Solitary

Pulmonary Nodule, Multiple

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

This is a study that will evaluate the utility of a scatter reduction technique in reducing dose and increasing the sensitivity of stationary digital chest tomosynthesis (s-DCT) in the detection of lu...

Detailed Description

Digital tomosynthesis is an imaging modality that produces 3D sectional information using x-ray projections acquired over a limited scanning angle. Scatter is known to be the primary source of image d...

Eligibility Criteria

Inclusion

  • Patients with known lung lesion(s)
  • Patients having undergone a chest CT
  • Patients 18 years of age and older
  • Patients able to provide informed consent

Exclusion

  • Patients who may not fit on a 35 x 35 detector (BMI \> 35)
  • Planned procedures or therapies during study (in between SOC scans and study scan on s-DCT) (biopsy or removal of lung lesion)
  • Any woman who is pregnant, has reason to believe she is pregnant, or is lactating

Key Trial Info

Start Date :

August 26 2020

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

August 26 2021

Estimated Enrollment :

38 Patients enrolled

Trial Details

Trial ID

NCT04076696

Start Date

August 26 2020

End Date

August 26 2021

Last Update

August 8 2022

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

University of North Carolina at Chapel Hill

Chapel Hill, North Carolina, United States, 27599

Clinical Evaluation of Primary Sampling Scatter Correction for Chest Tomosynthesis | DecenTrialz